About 17,968 results

Tirzepatide: 'Exciting' and Promising in Lowering A1c

May 23rd, 2022 - This transcript has been edited for clarity. The FDA just approved tirzepatide as the first dual GIP/GLP-1 (glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1) receptor agonist on the market for treating type 2 diabetes. The indication that it currently has is reducing glucose in patients with type 2 diabetes who are not successful with diet and exercise. It doesn't yet have a...

Thrombolysis Safe in Stroke Patients on Oral Anticoagulants

May 23rd, 2022 - Intravenous thrombolysis (IVT) for acute stroke appears safe for patients who have recently received direct oral anticoagulant (DOAC) therapy, a new observational study suggests, prompting researchers to ask whether guidelines that restrict its use should be updated. Researchers found that DOAC users were significantly less likely to develop symptomatic intracerebral hemorrhage (sICH) after IVT...

Medicare Is Right to Refuse to Pay for Costly Alzheimer's Drug, Says Ethicist

May 11th, 2022 - This transcript has been edited for clarity. Hi. I'm Art Caplan. I'm at the New York University Grossman School of Medicine, where I direct the Division of Medical Ethics. Early in April, we had a really interesting decision by a group that usually doesn't make decisions like this. The Centers for Medicare & Medicaid Services (CMS), the agency that runs Medicare, made a decision that it was not...

Experts Show How to Reduce School-Related Sedentary Behavior

May 2nd, 2022 - This article was originally published in Italian on Univadis. "To provide guidance to parents, educators, policymakers, researchers, and healthcare providers" ― this was the main objective of the Sedentary Behavior Research Network (SBRN) team that guided the development of the recommendations published in International Journal of Behavioral Nutrition and Physical Activity. The article, "Intern...

More than half of Americans have had COVID infections -U.S. study

Apr 27th, 2022 - (Reuters) -Following the record surge in COVID-19 cases during the Omicron-driven wave, some 58% of the U.S. population overall and more than 75% of younger children have been infected with the coronavirus since the start of the pandemic, according to a U.S. nationwide blood survey released on Tuesday. The study issued by the U.S. Centers for Disease Control (CDC) and Prevention marks the first...

EXCLUSIVE-EU to move away from emergency phase of COVID pandemic - document

Apr 26th, 2022 - BRUSSELS, April 26 (Reuters) - The European Commission is set to say the EU has entered a new post-emergency phase of the pandemic in which testing should be targeted and monitoring of COVID-19 cases should be similar to sample-based flu surveillance, according to a draft document seen by Reuters. The shift comes amid a gradual drop of cases and a fall in the number of deaths linked to COVID-19...

Mexico to enable COVID vaccination of all children aged 12 and above

Apr 26th, 2022 - MEXICO CITY (Reuters) - Mexico will let all children aged over 12 be registered for COVID-19 vaccination from Thursday, Deputy Health Minister Hugo Lopez-Gatell said. Lopez-Gatell, the country’s coronavirus czar, was speaking at a regular government news conference on Tuesday.

Alcohol Dependence Drug the Next Anti-Anxiety Med?

Apr 21st, 2022 - Disulfiram, a US Food and Drug Admiistration (FDA)–approved medication for the treatment of chronic alcohol dependence, shows promise as a potential anxiolytic, early research suggests. Japanese researchers, headed by Akiyoshi Saitoh, PhD, professor in the Department of Pharmacy, Tokyo University of Science, compared the reactions of mice that received a classic anxiolytic agent (diazepam) to t...

Omicron sub-variant BA.2 makes up nearly 75% of COVID variants in U.S. - CDC

Apr 19th, 2022 - April 19 (Reuters) - The BA.2 sub-variant of Omicron is estimated to make up 74.4% of the coronavirus variants in the United States as of April 16, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday. Last week, the agency said the sub variant made up 86% of U.S. COVID-19 cases as of April 9. (Reporting by Bhanvi Satija in Bengaluru; Editing by Aditya Soni)

Poland declines to take or pay for more COVID-19 vaccines for now

Apr 19th, 2022 - WARSAW (Reuters) -Poland will not take or pay for more doses of COVID-19 vaccine under the European Union’s supply contract, its health minister said on Tuesday, setting the stage for a legal battle with manufacturers. Poland, along with other EU members, has been receiving COVID-19 vaccines during the coronavirus pandemic under supply contracts agreed between the European Commission and vaccin...

Moderna says dual variant booster with Beta more effective vs Omicron than current shot

Apr 19th, 2022 - (Reuters) - Moderna Inc on Tuesday said a COVID-19 booster designed to target the Beta variant as well as the original coronavirus generated a better immune response against a number of virus variants including Omicron. Moderna said the results were a good sign for the company’s plans for future shots targeting two COVID-19 variants. Dr. Jacqueline Miller, a top Moderna scientist, said the comp...

Analysis-Demand for Pfizer's COVID pills lags around the world

Apr 19th, 2022 - (Reuters) - Worldwide demand for Pfizer Inc’s oral COVID-19 antiviral treatment Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced testing, and potential for drug interactions, a Reuters review of data and interviews with experts has found. Demand also has been hampered by the perception that Omicron infections are not that severe. Paxlovid was expected to...

Poland says it won't take or pay for more COVID-19 vaccines for now

Apr 19th, 2022 - WARSAW, April 19 (Reuters) - Poland won’t take or pay for more doses of COVID-19 vaccine under the European Union’s supply contract, its health minister said on Tuesday, setting the stage for a legal battle with manufacturers. Poland, along with other EU members, has been receiving COVID-19 vaccines during the coronavirus pandemic under supply contracts agreed between the European Commission an...

COVID SCIENCE-Omicron infection induces limited immune response in unvaccinated; COVID hospital deaths rise on weekends

Apr 18th, 2022 - April 18 (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Omicron infection induces limited immune response Unvaccinated people infected with the Omicron variant are unlikely to develop immune responses that will protect them against other vari...

FACTBOX-Worldwide coronavirus cases cross 500.92 million, death toll at 6,588,921

Apr 15th, 2022 - (Reuters) - More than 500.92 million people have been reported to be infected by the novel coronavirus globally and 6,588,921 have died, according to a Reuters tally. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019. Interactive graphic tracking global spread of coronavirus: open tmsnrt.rs/2FThSv7 in an exte...

Omicron sub-variant BA.2 makes up 85.9% of COVID variants in U.S. - CDC

Apr 12th, 2022 - April 12 (Reuters) - The BA.2 sub-variant of Omicron is estimated to make up 85.9% of the coronavirus variants in the United States as of April 9, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday. A resurgence in COVID-19 cases in parts of Asia and Europe has raised concerns that another wave could follow in the United States, but the country’s health experts believe it...

CapVest sweetens bid for Australia's Virtus Health in $515 million deal

Apr 11th, 2022 - (Reuters) -Australian fertility services provider Virtus Health Ltd said on Monday it had received a fresh takeover offer of A$692 million ($515.06 million) from CapVest Partners LLP, trumping a rival bid from top investor BGH Capital. The A$8.1 per share offer by UK-based investment firm CapVest was at a 0.6% discount to Virtus’ last close on April 6, after which its shares were placed in a tr...

FDA says GSK-Vir's sotrovimab no longer authorized to treat COVID in U.S.

Apr 5th, 2022 - April 5 (Reuters) - The U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology’s drug sotrovimab was no longer authorized to treat COVID-19 in the U.S. due to an increase in the proportion of cases caused by the Omicron BA.2 sub-variant. (Reporting by Leroy Leo in Bengaluru; Editing by Shounak Dasgupta)

Fitness company Tivity Health to be bought by Stone Point Capital for $2 billion

Apr 5th, 2022 - (Reuters) -Fitness company Tivity Health said on Tuesday it had agreed to be bought and taken private by investment firm Stone Point Capital for $2 billion in cash. Tivity said its stockholders would receive $32.50 per share, which is a near 1% premium to the stock’s closing price of $32.25 on Monday. Tivity’s shares rose 0.5% to $32.42 in morning trade. The company owns SilverSneakers, a fitne...

UPDATE 1-Pfizer made 6 mln courses of COVID pill, hitting Q1 target

Apr 4th, 2022 - (Adds details) April 4 (Reuters) - Pfizer Inc said on Monday it made 6 million courses of its antiviral COVID-19 pill Paxlovid in the first quarter, hitting a target set by Chief Executive Albert Bourla. Pfizer spokesperson Sharon Castillo said in an email that the company has shipped the pills to over 26 countries so far. Bourla has said the company expects to produce at least 120 million cour...